Kura Oncology, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focused on the discovery and development of innovative therapies for cancer. The company's pipeline includes targeted therapies that aim to address unmet medical needs in oncology, particularly for patients with genetically defined tumors. With a robust clinical development program and strategic partnerships, Kura Oncology is poised to advance its leading drug candidates and enhance treatment options for cancer patients.